None listed
Conditions
Brief summary
In a view to improve pulmonary functions this study will be conducted in the Fever clinic, BSMMU and Kurmitola General Hospital, Dhaka. A total of 155 patients with COVID-19 will included in this study. Study population will be confirmed by laboratory findings. Patients will be selected for the study by specific inclusion and exclusion criteria. Informed consent will be taken properly. Patients will be provided pulmonary rehabilitation treatment along with standard treatment in one group and another one group will be provided standard treatment only. Randomization of the patients into two groups will be done by the way of lottery. Pulmonary rehabilitation procedure will be given by a trained Physiotherapist under the supervision of a Physiatrist. Rehabilitation treatment will be given daily for four weeks. Follow up of the patient will be done weekly. The gathered data will be analyzed statistically. Both paired and unpaired Student’s ‘t’ test and Chi-squired test will be done as required. By this study, the respiratory capacity of the patient can be increased and ultimately lung complication may be reduced.
Interventions
Pulmonary rehabilitation: Pulmonary rehabilitation will be provided as intervention along with standard treatment, and it will be given by the same Physiotherapist under direct supervision of a Physiatrist properly. Pulmonary rehabilitation will be delivered daily for 4 weeks, each session is anticipated to take 15 minutes to complete. And a Bangla written pulmonary rehabilitation procedure document (which is designed for this study only) will be provided to the patients who will be treated at home & they will be supervised virtually over video calls. Pulmonary rehabilitation is as follows: 1. Prone positioning, 2. Chest Physical therapy: Positioning>cupping>vibration>suction and Ventilator muscle strength training and 3.Breathing exercises. These are the intervention for one group along with standard treatment and other group will be treated with standard treatment only as per WHO guideline.
Sponsors
Study design
Eligibility
Inclusion criteria
• Nasopharyngeal swab samples (tested by RT-PCR) positive for the novel coronavirus. • Subjects Aged 15 years or more of all genders. • Oxygen saturation as measured by pulse oximetry (SpO2) greater than 90 % in room air. • Patients having symptoms mild to moderate in nature • A resting respiratory rate 30/m or less than 30/m. • Able to understand the content of questionnaires and who will provide informed consent.
Exclusion criteria
• Subjects aged more than 70 years of all genders. • Subjects having severe form of COVID-19 • Subjects having severe COPD, bronchial asthma and severe ischemic heart disease. • Pregnant woman will be excluded from the study.